Publications in Medicines Safety
The WHO Medicines Safety team brings together global expertise in developing norms and standards for pharmacovigilance (PV). The resulting publications are available to Member States. New information on serious adverse effects of medicines and regulatory actions are published in the WHO Pharmaceuticals Newsletter and as one-page Drug Alerts. Relevant regulatory decisions are ultimately compiled in the United Nations Consolidated List of Products Whose Consumption and/or Sale Have Been Banned, Withdrawn, Severely Restricted or not Approved by Governments. WHO publishes updates to this list: Pharmaceuticals: Restrictions in use and availability.
Full list of Publications
Check the full list of publications within the Medicines Publications link in the left column. Before getting started, please, read carefully our How to Find Information manual here .
A practical handbook on the pharmacovigilance of medicines used in the treatment of tuberculosis
- Clinical Pharmacology: in Health Care, Teaching and Research
Safety monitoring of medicinal products: reporting system for the general public’
- Drug alerts
Joining the WHO Programme for International Drug Monitoring
- Pharmaceuticals: restrictions in use and availability
Minimum Requirements for a functional Pharmacovigilance System
- Recommendations from WHO Advisory Committee on Safety of Medicinal Products (ACSoMP)
- Safety Monitoring of Medicinal Products: Guidelines for Setting Up and Running a Pharmacovigilance Centre
- WHO Drug information
- WHO Pharmaceuticals Newsletter